Health News

ecigeratte-oct18.jpgAt a time, when e-cigarettes have been getting a lot of bad press, a new study has found a positive association between the number of people using e-cigarettes and the success rate of giving up smoking. The study led by Dr. Emma Beard, UCL Division of Psychology and Language Sciences, showed that...
Read More

Canadian cannabis company Aphria Inc. said it's subsidiary has received a European Union Good Manufacturing Practices or EU GMP certification that will allow the company to begin supplying medical cannabis to the European Union. Aphria said it's subsidiary ARA - Avanti Rx Analytics received the certification...
Read More

Interstitial Cystitis Drug Linked To Retinal Damage: Study

Elmiron, the only FDA-approved oral drug to treat interstitial cystitis, also known as bladder pain syndrome, has been found to be associated with a vision-threatening eye condition, according to a new study.
Read More

No Piggy Tale: Some Brain Functions Restored Even Hours After Death

The conventional wisdom is that if the brain cells of humans and other mammals are deprived of oxygen for 4-5 min, they begin to die, and that the loss of brain functions after death is irreversible. But the findings of a study conducted by Yale University researchers challenge these long-held assumptions.
Read More
bornbaby-sept30.jpgA recent study, done by researchers from the Wellcome Sanger Institute, UCL, the University of Birmingham and their collaborators, found that there is a difference in the gut bacteria of babies delivered vaginally and those born via caesarean.
Read More
Follow RTT

FDA Calendar
Event DateSymbolDrug NameEvent Name
04/17/20AZN.L, AZNTrastuzumab deruxtecan (BLA)FDA decision on Trastuzumab deruxtecan or treatment of patients with HER2-positive metastatic breast cancer
04/04/20LLYEmpagliflozin/Iinagliptin/Metformin Triple Combination Tablet (NDA)FDA decision on the triple combination tablet for adults with Type 2 Diabetes
04/04/20BMYLuspatercept (BLA)FDA decision on Luspatercept for adult patients with very low- to intermediate-risk MDS-associated anemia
04/04/20XLRNLuspatercept (BLA)FDA decision on Luspatercept for adult patients with very low- to intermediate-risk MDS-associated anemia
03/28/20RMTIIV Triferic (NDA)FDA decision on IV Triferic for iron deficiency in chronic kidney disease patients receiving hemodialysis
03/26/20HRTXHTX-011 (Resubmitted NDA)FDA decision on HTX-011 for the management of postoperative pain
View All